Compare PWP & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PWP | QDEL |
|---|---|---|
| Founded | 2006 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2020 | 2022 |
| Metric | PWP | QDEL |
|---|---|---|
| Price | $21.60 | $12.88 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $23.50 | ★ $28.25 |
| AVG Volume (30 Days) | 758.0K | ★ 2.7M |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.30% | N/A |
| EPS Growth | ★ 138.52 | 45.35 |
| EPS | ★ 0.47 | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $31.87 | $3.51 |
| Revenue Next Year | $16.54 | $3.86 |
| P/E Ratio | $45.85 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.59 | $11.61 |
| 52 Week High | $25.93 | $37.24 |
| Indicator | PWP | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 73.99 | 36.27 |
| Support Level | $20.70 | N/A |
| Resistance Level | $23.01 | $30.65 |
| Average True Range (ATR) | 0.87 | 1.30 |
| MACD | 0.40 | -0.00 |
| Stochastic Oscillator | 78.79 | 19.82 |
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.